1. Home
  2. ICL vs HALO Comparison

ICL vs HALO Comparison

Compare ICL & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICL Group Ltd.

ICL

ICL Group Ltd.

HOLD

Current Price

$5.05

Market Cap

6.3B

Sector

Industrials

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$68.36

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICL
HALO
Founded
1968
1998
Country
Israel
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
7.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ICL
HALO
Price
$5.05
$68.36
Analyst Decision
Hold
Buy
Analyst Count
3
12
Target Price
$6.23
$73.33
AVG Volume (30 Days)
936.6K
2.6M
Earning Date
11-12-2025
11-03-2025
Dividend Yield
3.88%
N/A
EPS Growth
N/A
56.68
EPS
0.29
4.74
Revenue
$7,053,000,000.00
$1,242,852,000.00
Revenue This Year
$5.82
$34.83
Revenue Next Year
$5.42
$24.84
P/E Ratio
$17.42
$14.22
Revenue Growth
1.77
31.19
52 Week Low
$4.70
$46.26
52 Week High
$7.35
$79.50

Technical Indicators

Market Signals
Indicator
ICL
HALO
Relative Strength Index (RSI) 39.91 56.82
Support Level $4.95 $61.23
Resistance Level $5.05 $66.60
Average True Range (ATR) 0.09 2.08
MACD 0.02 0.48
Stochastic Oscillator 45.79 86.10

Price Performance

Historical Comparison
ICL
HALO

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: